STAAR Surgical Company
NASDAQ:STAA · NASDAQ Global Market
-$0.40 today
Vol 0.74M · Avg 1.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+74.58%
Period High
$33.34
Period Low
$16.10
Latest
$29.12
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.82B
NovoCure Limited
NASDAQ:NVCR
$1.69B
Precigen, Inc.
NASDAQ:PGEN
$1.39B
BioLife Solutions, Inc.
NASDAQ:BLFS
$1.26B
Tourmaline Bio, Inc.
TRML
$1.23B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.12B
Azenta, Inc.
NASDAQ:AZTA
$1.05B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$884.04M
Beta Bionics, Inc.
NASDAQ:BBNX
$611.39M
What is the latest STAA filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does STAA have?
Intrinsic Alpha currently shows 20 recent filings for STAA.
Explore More
Continue the stock analysis
Jump to another research area for this company.